Home > Qtrly Results > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Quarterly Results Analysis [Mar2026]

GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹995 Cr ₹1,041 Cr ₹980 Cr ₹805 Cr ₹974 Cr ₹949 Cr ₹1,011 Cr ₹815 Cr
Expenses ₹644 Cr ₹670 Cr ₹644 Cr ₹554 Cr ₹641 Cr ₹658 Cr ₹689 Cr ₹584 Cr
Operating Income ₹351 Cr ₹371 Cr ₹336 Cr ₹251 Cr ₹333 Cr ₹292 Cr ₹322 Cr ₹231 Cr
Other Income ₹36 Cr ₹32 Cr ₹34 Cr ₹44 Cr ₹41 Cr ₹35 Cr ₹35 Cr ₹36 Cr
Interest ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹13 Cr ₹20 Cr ₹17 Cr ₹16 Cr ₹15 Cr ₹19 Cr ₹17 Cr ₹16 Cr
Profit Before Tax ₹373 Cr ₹400 Cr ₹354 Cr ₹279 Cr ₹359 Cr ₹308 Cr ₹344 Cr ₹249 Cr
Profit After Tax ₹278 Cr ₹296 Cr ₹257 Cr ₹205 Cr ₹263 Cr ₹230 Cr ₹253 Cr ₹182 Cr
EPS ₹16.40 ₹17.45 ₹15.20 ₹12.10 ₹15.52 ₹13.57 ₹14.90 ₹10.76
Industry Peers & Returns1W1M1Y
GLAXOSMITHKLINE PHARMACEUTICALS 1.2% -9.8% -37.5%
SUN PHARMACEUTICAL INDUSTRIES 0.8% -4.2% 7%
DIVIS LABORATORIES 1.1% -0.7% -1%
TORRENT PHARMACEUTICALS 0% 1.3% 40.1%
CIPLA -0.3% -4.1% -8.6%
DR REDDYS LABORATORIES 0.4% -4.5% -5.2%
MANKIND PHARMA -0.6% -5.9% 0.1%
LUPIN 1.3% 0.1% 13.3%
ZYDUS LIFESCIENCES -1.8% 6.6% 10.8%

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-4.41 %

Y-o-Y

2.15 %

Quarters Revenues % Change
Mar2026 ₹995 Cr
-4.41
Dec2025 ₹1,041 Cr
6.26
Sep2025 ₹980 Cr
21.71
Jun2025 ₹805 Cr
-17.37
Mar2025 ₹974 Cr
2.63
Dec2024 ₹949 Cr
-6.07
Sep2024 ₹1,011 Cr
24.07
Jun2024 ₹815 Cr -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-5.50 %

Y-o-Y

5.32 %

Quarters Operating Profit % Change
Mar2026 ₹351 Cr
-5.50
Dec2025 ₹371 Cr
10.61
Sep2025 ₹336 Cr
33.65
Jun2025 ₹251 Cr
-24.61
Mar2025 ₹333 Cr
14.14
Dec2024 ₹292 Cr
-9.26
Sep2024 ₹322 Cr
39.55
Jun2024 ₹231 Cr -
Operating Margins
Q-o-Q

-1.12 %

Y-o-Y

3.10 %

Quarters Operating Margin% % Change
Mar2026 35.26%
-1.12
Dec2025 35.66%
4.09
Sep2025 34.26%
9.81
Jun2025 31.2%
-8.77
Mar2025 34.2%
11.22
Dec2024 30.75%
-3.39
Sep2024 31.83%
12.47
Jun2024 28.3% -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-6.01 %

Y-o-Y

5.70 %

Quarters Profit After Tax % Change
Mar2026 ₹278 Cr
-6.01
Dec2025 ₹296 Cr
14.81
Sep2025 ₹257 Cr
25.60
Jun2025 ₹205 Cr
-22.01
Mar2025 ₹263 Cr
14.35
Dec2024 ₹230 Cr
-8.96
Sep2024 ₹253 Cr
38.49
Jun2024 ₹182 Cr -
PAT Margins
Q-o-Q

-1.66 %

Y-o-Y

3.48 %

Quarters PAT Margin(%) % Change
Mar2026 27.92 %
-1.66
Dec2025 28.39 %
8.03
Sep2025 26.28 %
3.22
Jun2025 25.46 %
-5.63
Mar2025 26.98 %
11.44
Dec2024 24.21 %
-3.08
Sep2024 24.98 %
11.62
Jun2024 22.38 % -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-6.02 %

Y-o-Y

5.67 %

Quarters EPS % Change
Mar2026 ₹16.4
-6.02
Dec2025 ₹17.45
14.80
Sep2025 ₹15.2
25.62
Jun2025 ₹12.1
-22.04
Mar2025 ₹15.52
14.37
Dec2024 ₹13.57
-8.93
Sep2024 ₹14.9
38.48
Jun2024 ₹10.76 -

You may also like the below Video Courses